Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
OXFORD CANCER ANALYTICS LTD
Active- 12437885Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Inventa, Botley Road, Oxford OX2 0HA
- Classification (2 SIC codes)
- Research and experimental development on biotechnology (72.11 - SIC 2007)Other human health activities (86.90 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
Every document filed at Companies House for this company.
Pre-Score for UK companies is coming soon
- 23/09/2026View PDF (2 pages)
Appointment of Mr Heinrich Dreismann as a director on 2026-09-01
- 06/08/2026View PDF (1 pages)
Resolutions
- 06/08/2026View PDF (57 pages)
Memorandum and Articles of Association
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 02/02/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures OXFORD CANCER ANALYTICS LTD filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£8.39M2024
317.69%vs 20232023: £2.01M
Total Assets
£8.63M2024
275.10%vs 20232023: £2.30M
Cash in Bank
£8.19M2024
989.30%vs 20232023: £751.73K
Total Liabilities
£22.10K2024
50.51%vs 20232023: £14.69K
Employees
132024
+2vs 20232023: 11
Of the 4 measures with an earlier filing to compare against, 4 rose. Cash in bank moved furthest, up 989.30% on 2023. See the full financial analysis for OXFORD CANCER ANALYTICS LTD.
The full financial record
Four ways through OXFORD CANCER ANALYTICS LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +196% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2022–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 13 | +2 |
| 2023 | 11 | +4 |
| 2022 | 7 | – |
Reported employee count increased from 7 in 2022 to 13 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
11Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 27/06/2023–19/11/2024 | 1 | |
| Director | 19/11/2024–Present | 1 | |
| Director | 30/06/2025–Present | 1 | |
| Director | 03/02/2020–10/10/2025 | 0 | |
| Director | 03/02/2020–Present | 0 | |
| Director | 19/11/2024–Present | 4 | |
| Director | 30/06/2021–26/01/2026 | 0 | |
| Director | 27/08/2021–27/06/2023 | 0 | |
| Director | 30/06/2021–Present | 0 | |
| Director | 03/06/2026–Present | 0 | |
| Director | 01/09/2026–Present | 0 |
Persons with significant control
5Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 03/02/2020–27/11/2024 | 0 | |
| 03/02/2020–Present | 0 | |
| 02/02/2020–Present | 0 | |
| 03/02/2020–Present | 0 | |
| 03/02/2020–27/11/2024 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 3 Since 06/08/2026
- Last 12 months
- 3
- Most recent filing
- 23/09/2026 less than a month ago
What changed in the last year
- Officer changesLatest 23/09/2026
Filing timeline
- 23/09/2026View PDF (2 pages)
Appointment of Mr Heinrich Dreismann as a director on 2026-09-01
- 06/08/2026View PDF (1 pages)
Resolutions
- 06/08/2026View PDF (57 pages)
Memorandum and Articles of Association
See when the next accounts and confirmation statement are due
Similar companies
40 UK companies are similar to OXFORD CANCER ANALYTICS LTD, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
LINICAL UK LIMITED
ActiveMeacher-Jones, 6 St John's Court, Vicars Lane, Chester, Cheshire CH1 1QE
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09318613
- Incorporated
- 19/11/2014
- Employees
- 13
BIOCORTEX LTD
Active167-169 Great Portland Street, London W1W 5PF
- Activity
- Research and experimental development on biotechnology
- Company no.
- 13287534
- Incorporated
- 23/03/2021
- Employees
- 13
LABOUR RESEARCH DEPARTMENT
Active3 St George's Mews, Westminster Bridge Road, London SE1 7JB
- Activity
- Research and experimental development on social sciences and humanities
- Company no.
- 11429402
- Incorporated
- 22/06/2018
- Employees
- 11
ALGAECYTES LIMITED
ActiveCamburgh House, 27 New Dover Road, Canterbury, Kent CT1 3DN
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 07264317
- Incorporated
- 25/05/2010
- Employees
- 13
APPLIED AGI LIMITED
Active1 Friar Street, Reading RG1 1DA
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12211733
- Incorporated
- 17/09/2019
- Employees
- 14
About OXFORD CANCER ANALYTICS LTD
A short description of the company, written from its Companies House record.
OXFORD CANCER ANALYTICS LTD is a private limited company registered in the United Kingdom, based in Inventa, Botley Road, Oxford OX2 0HA. Companies House classifies its business as Research and experimental development on biotechnology, one of 2 SIC classifications on its record. It has been on the register for 6 years 7 months.
The register currently records it as active. Its 2024 accounts report net assets of £8.39M and 13 employees.
OXFORD CANCER ANALYTICS LTD: frequently asked questions
Answered from this company's own registry record and filed figures.
What does OXFORD CANCER ANALYTICS LTD do?
Companies House records OXFORD CANCER ANALYTICS LTD under 2 registered business activities: Research and experimental development on biotechnology (72.11 - SIC 2007) and Other human health activities (86.90 - SIC 2007).
Is OXFORD CANCER ANALYTICS LTD still active?
OXFORD CANCER ANALYTICS LTD is recorded as active on the Companies House register, and has been on it since 03/02/2020.
What are OXFORD CANCER ANALYTICS LTD's latest reported financials?
The most recent accounts Okredo holds cover 2024 and report net assets of £8.39M, total assets of £8.63M, cash in bank of £8.19M and total liabilities of £22.10K.
When did OXFORD CANCER ANALYTICS LTD last file with Companies House?
The most recent document on the record is dated 23/09/2026: Appointment of Mr Heinrich Dreismann as a director on 2026-09-01, less than a month ago.
When are OXFORD CANCER ANALYTICS LTD's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs OXFORD CANCER ANALYTICS LTD?
Companies House lists 11 officers (7 currently in post) and 5 people with significant control (3 current).